SCHEMBL2155208

SCHEMBL2155208

CC[P](=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TP53 P04637 1/20 0.38
PSIP1 O75475 1/20 0.37
ESR1 P03372 3/20 0.34
ESR2 Q92731 3/20 0.34
KCNN4 O15554 1/20 0.34
ALDH1A1 P00352 3/20 0.33
CES2 O00748 3/20 0.33
CES1 P23141 3/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
TSHR P16473 1/20 0.32
KDM4E B2RXH2 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27595165 0.87 ESR1 (0.32) CYP3A4TDP1TP53PSIP1ESR1
SCHEMBL5572991 0.80 TDP1 (0.38) CYP3A4TDP1TP53PSIP1ESR1
SCHEMBL17670017 0.77 CES2 (0.37) CYP3A4TDP1CES2CES1KDM4E
SCHEMBL27587243 0.76 TDP1 (0.43) CYP3A4TDP1ESR1ESR2ALDH1A1
SCHEMBL27380516 0.75 GAA (0.40) CYP3A4TDP1TP53ALDH1A1MEN1
SCHEMBL28290968 0.75 CES2 (0.39) CYP3A4TDP1TP53CES2CES1
SCHEMBL28215717 0.75 ALDH1A1 (0.35) CYP3A4TDP1PSIP1ALDH1A1MEN1
SCHEMBL27769845 0.74 CYP3A4 (0.41) CYP3A4TDP1ESR1ESR2ALDH1A1
SCHEMBL9769194 0.73 CES2 (0.41) TDP1ALDH1A1CES2CES1
SCHEMBL20377375 0.73 TDP1 (0.36) CYP3A4TDP1ESR1ESR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120025371-A Preparation method of phosphorus-containing nitrogen heterocyclic compound 河北科技大学 2025-05-23 CN disclosed
CN-119800065-A Tungsten extractant, preparation method thereof and method for extracting and separating tungsten 郑州大学 2025-04-11 CN disclosed
EP-3643720-B1 ORGANIC COMPOUNDS, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC ELECTRONIC DEVICE NOVALED GMBH (DE) 2021-09-29 EP disclosed
WO-2021031343-A1 PHOSPHORUS-CONTAINING FLAME-RETARDANT LOW-THERMAL-EXPANSION COEFFICIENT EPOXY RESIN, PREPARATION METHOD AND USE THEREOF 苏州巨峰电气绝缘系统股份有限公司 2021-02-25 WO disclosed
EP-3643720-A1 ORGANIC COMPOUNDS, ORGANIC SEMICONDUCTOR LAYER AND ORGANIC ELECTRONIC DEVICE Novaled GmbH (DE) 2020-04-29 EP disclosed
US-10479809-B2 Method for producing alkenyl phosphorus compound MARUZEN PETROCHEMICAL CO., LTD. (JP) 2019-11-19 US disclosed
US-20190263847-A1 METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND MARUZEN PETROCHEMICAL CO., LTD. (JP) 2019-08-29 US disclosed
EP-3184171-B1 PHOSPHINYL AMIDINE COMPOUNDS, METAL COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OR POLYMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2019-03-20 EP disclosed
EP-2858750-B1 PHOSPHINYL GUANIDINE COMPOUNDS, CHROMIUM SALT COMPLEXES, CATALYST SYSTEMS, AND THEIR USE TO OLIGOMERIZE OLEFINS CHEVRON PHILLIPS CHEMICAL CO LP (US) 2019-03-13 EP disclosed
US-10144752-B2 Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2018-12-04 US disclosed
US-5292526-A Macroemulsion of non-cationic antibacterial agent COLGATE-PALMOLIVE CO. (US) 1994-03-08 US disclosed
US-5288480-A Antiplaque antibacterial oral composition COLGATE-PALMOLIVE CO. (US) 1994-02-22 US disclosed
US-5192530-A Solubilizer, enhancing agent to aid retention, and delivery enhancement COLGATE-PALMOLIVE COMPANY (US) 1993-03-09 US disclosed
US-5192531-A Triclosan as a water insoluble noncationic additive for dentifrices COLGATE-PALMOLIVE COMPANY (US) 1993-03-09 US disclosed
US-5188821-A ANTIBACTERIAL ANTIPLAQUE ORAL COMPOSITION MOUTHWASH OR LIQUID DENTIFRICE COLGATE-PALMOLIVE COMPANY (US) 1993-02-23 US disclosed
US-5180578-A Adhesion to oral surfaces COLGATE-PALMOLIVE COMPANY (US) 1993-01-19 US disclosed
US-5178851-A Dentifrices treatment with triclosan and carriers COLGATE-PALMOLIVE COMPANY (US) 1993-01-12 US disclosed
US-5032386-A Dentistry COLGATE-PALMOLIVE COMPANY (US) 1991-07-16 US disclosed
US-4119780-A 2(Isopropyldithio)benzimidazole MONSANTO COMPANY (US) 1978-10-10 US disclosed
US-4006155-A Method for preparation of phosphorus polysulfides MONSANTO COMPANY (US) 1977-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10144752-B2 Phosphinyl amidine compounds, metal complexes, catalyst systems, and their use to oligomerize or polymerize olefins NIT2, NCLN, NPM1 CYP3A4 4787/4885TDP1 3539/4885TP53 1644/4885
US-10479809-B2 Method for producing alkenyl phosphorus compound ORC3, OR10J3, ORAI3 CYP3A4 53/4885TDP1 3180/4885TP53 3347/4885
US-20190263847-A1 METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND ORC3, OR10J3, ALK CYP3A4 71/4885TDP1 3486/4885TP53 3581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.